These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2389484)

  • 21. Influence of simultaneous pancreas and kidney transplantation on renal graft survival.
    Ricart MJ; Bacqué MC; Esmatjes E; Oppenheimer F; Vilardell J; Campistol JM; Carretero P; Fernández-Cruz L
    Transplant Proc; 1995 Aug; 27(4):2237-8. PubMed ID: 7652788
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of HLA matching on graft survival in live donor kidney transplantations.
    Velidedeoğlu E; Bilgin N; Haberal M
    Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
    [No Abstract]   [Full Text] [Related]  

  • 23. HLA matching and short/long-term outcome of cadaveric renal allografts: large single-centre data confirm the multicentre analyses.
    Petersen P; Schneeberger H; Schleibner S; Illner WD; Hofmann GO; Scholz S; Albert ED; Land W
    Transplant Proc; 1995 Feb; 27(1):651-2. PubMed ID: 7879131
    [No Abstract]   [Full Text] [Related]  

  • 24. Local use of kidneys with poor HLA matches is as good as shared use with good matches in the cyclosporine era: an analysis at one and two years.
    Alexander JW; Vaughn WK; Pfaff WW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):672-4. PubMed ID: 3274836
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of HLA matching supersedes many others for long-term cadaver kidney transplants.
    Milgrom M; Gomez C; Esquenazi V; Olson L; Roth D; Miller J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):675-6. PubMed ID: 2650218
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of HLA typing in clinical kidney transplants: 30 years later.The case for years of functioning kidney transplant (YFT).
    Thompson JS
    Clin Transpl; 1993; ():436-41. PubMed ID: 7918178
    [No Abstract]   [Full Text] [Related]  

  • 28. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts.
    Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317
    [No Abstract]   [Full Text] [Related]  

  • 29. Beneficial HLA matching: its phase of impact on graft survival.
    Gilks WR; Bradley BA; Gore SM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):664-5. PubMed ID: 3274833
    [No Abstract]   [Full Text] [Related]  

  • 30. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
    Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal regrafts.
    Imagawa DK; Cecka JM
    Clin Transpl; 1988; ():387-98. PubMed ID: 3154489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One thousand renal transplants in Belfast (1968-1998).
    Middleton D; Douglas JF; Opelz G; Doehler B; McGeown MG
    Clin Transpl; 2004; ():151-64. PubMed ID: 16704148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dialysis method and kidney graft survival.
    Kyllönen L; Helanterä A; Salmela K; Ahonen J
    Transplant Proc; 1992 Feb; 24(1):354. PubMed ID: 1539314
    [No Abstract]   [Full Text] [Related]  

  • 36. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
    Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
    Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
    [No Abstract]   [Full Text] [Related]  

  • 37. Results of 1074 kidney transplants in Chile.
    Meléndez M; Elgueta S; Wegmann ME; Santamaría L; Fuentes C
    Transplant Proc; 1993 Jun; 25(3):2386-8. PubMed ID: 8516936
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of reexposure to mismatched major histocompatibility complex antigens on renal retransplant allograft survival.
    Farney AC; Noreen HJ; Sutherland DE; Reinsmoen N; Segall M; Gillingham K; Schmidt WJ; Matas AJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):213-4. PubMed ID: 8438275
    [No Abstract]   [Full Text] [Related]  

  • 39. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
    Moen T; Berger L; Goyer K; Dahl O; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
    [No Abstract]   [Full Text] [Related]  

  • 40. Prednisone withdrawal in HLA-identical living related donor transplant recipients.
    Hariharan S; First MR; Munda R; Penn I; Schroeder TJ; Fidler J; Weiskittel P; Alexander JW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1617-9. PubMed ID: 2652526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.